Moderna (MRNA) News Today $34.06 +0.30 (+0.89%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Jim Cramer Says Moderna, Inc. (MRNA) Has Been ‘One Of The Biggest Disappointments Of The Year’January 19 at 4:50 PM | insidermonkey.comDespite Setbacks, Moderna Sees Opportunity In Avian Flu, Merck PartnershipJanuary 19 at 2:02 PM | seekingalpha.comIs Moderna Stock a Buy?January 19 at 4:55 AM | fool.com33,504 Shares in Moderna, Inc. (NASDAQ:MRNA) Purchased by Avanza Fonder ABAvanza Fonder AB purchased a new stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 33,504 shares of the company's stock, valued at approximately $1,393,000. A number of other institutional iJanuary 19 at 4:18 AM | marketbeat.comModerna confirms $590M award by U.S. for bird flu vaccine developmentJanuary 18 at 11:26 PM | markets.businessinsider.comJim Cramer Says Moderna, Inc. (MRNA) Is ‘So Luckless’January 18 at 10:04 PM | insidermonkey.comThese Were the 5 Worst-Performing Stocks in the S&P 500 in 2024January 18 at 9:30 AM | fool.comMorgan Stanley Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock PriceJanuary 18 at 4:11 AM | americanbankingnews.comFY2024 EPS Estimates for Moderna Reduced by AnalystJanuary 18 at 3:08 AM | americanbankingnews.comUS providing Moderna $590 mn to speed mRNA pandemic for bird flu which experts fear may start a pandemicJanuary 18 at 3:06 AM | msn.comU.S. Awards $590 Mln To Moderna For MRNA Pandemic Influenza Vaccine DevelopmentJanuary 18 at 3:06 AM | markets.businessinsider.comFY2024 EPS Estimates for Moderna Increased by William BlairModerna, Inc. (NASDAQ:MRNA - Free Report) - Research analysts at William Blair raised their FY2024 EPS estimates for Moderna in a report issued on Tuesday, January 14th. William Blair analyst M. Minter now forecasts that the company will post earnings of ($8.77) per share for the year, up from thJanuary 18 at 1:13 AM | marketbeat.comModerna Gets $590 Million in Federal Funding for Bird Flu VaccineJanuary 17 at 10:04 PM | wsj.comHHS invests nearly $600 million in Moderna’s bird flu vaccine developmentJanuary 17 at 10:04 PM | msn.comModerna gets $590M HHS contract to develop mRNA pandemic flu vaccinesJanuary 17 at 10:04 PM | seekingalpha.comUS health dept providing Moderna $590 mn to speed mRNA bird flu vaccineJanuary 17 at 10:04 PM | msn.comModerna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHSJanuary 17 at 10:04 PM | abcnews.go.comModerna Gets $590 Million of Federal Funding For Influenza VaccinesJanuary 17 at 6:02 PM | wsj.comModerna stock surges on bird flu vaccine fundingJanuary 17 at 4:58 PM | in.investing.comU.S. Gives Moderna $590 Million to Accelerate a Bird Flu VaccineJanuary 17 at 4:58 PM | msn.comUS awards Moderna $590 million for bird flu vaccine developmentJanuary 17 at 4:05 PM | reuters.comFY2024 Earnings Estimate for Moderna Issued By William BlairModerna, Inc. (NASDAQ:MRNA - Free Report) - Equities researchers at William Blair increased their FY2024 earnings per share (EPS) estimates for shares of Moderna in a note issued to investors on Tuesday, January 14th. William Blair analyst M. Minter now anticipates that the company will earn ($8.January 17 at 6:40 AM | marketbeat.comBrookline Capital Management Predicts Moderna FY2029 EarningsJanuary 17 at 4:55 AM | americanbankingnews.comTraders Purchase Large Volume of Put Options on Moderna (NASDAQ:MRNA)January 17 at 4:11 AM | americanbankingnews.comFY2024 EPS Estimates for Moderna Cut by Leerink PartnrsJanuary 17 at 1:13 AM | americanbankingnews.comInvestors Purchase Large Volume of Moderna Put Options (NASDAQ:MRNA)Moderna, Inc. (NASDAQ:MRNA - Get Free Report) was the recipient of unusually large options trading activity on Thursday. Stock investors acquired 221,493 put options on the company. This represents an increase of approximately 169% compared to the typical volume of 82,442 put options.January 16, 2025 | marketbeat.comLeerink Partners Cuts Moderna (NASDAQ:MRNA) Price Target to $27.00Leerink Partners decreased their price target on shares of Moderna from $31.00 to $27.00 and set an "underweight" rating on the stock in a research note on Thursday.January 16, 2025 | marketbeat.comModerna (NASDAQ:MRNA) Stock Price Expected to Rise, Berenberg Bank Analyst SaysBerenberg Bank lifted their price target on shares of Moderna from $33.00 to $42.00 and gave the company a "hold" rating in a report on Thursday.January 16, 2025 | marketbeat.comModerna Dropped by 20% This Week -- Is It a Smart Buy Right Now?January 16, 2025 | fool.comIs Moderna a Bad-News Buy for 2025?January 16, 2025 | fool.comFY2024 EPS Estimates for Moderna Lowered by AnalystModerna, Inc. (NASDAQ:MRNA - Free Report) - Equities research analysts at Brookline Capital Management cut their FY2024 earnings per share (EPS) estimates for Moderna in a research note issued on Monday, January 13th. Brookline Capital Management analyst L. Cann now expects that the company willJanuary 16, 2025 | marketbeat.comModerna FY2024 EPS Forecast Decreased by Leerink PartnrsModerna, Inc. (NASDAQ:MRNA - Free Report) - Investment analysts at Leerink Partnrs cut their FY2024 earnings per share (EPS) estimates for Moderna in a research note issued on Monday, January 13th. Leerink Partnrs analyst M. Foroohar now expects that the company will earn ($9.61) per share for thJanuary 16, 2025 | marketbeat.comDown 79%, Is Moderna Stock a Bad-News Buy on the Dip?January 16, 2025 | fool.comAnalysts Issue Forecasts for Moderna FY2029 EarningsModerna, Inc. (NASDAQ:MRNA - Free Report) - Analysts at Brookline Capital Management issued their FY2029 earnings per share estimates for Moderna in a research report issued on Monday, January 13th. Brookline Capital Management analyst L. Cann expects that the company will earn $22.02 per share fJanuary 16, 2025 | marketbeat.comIs Moderna (MRNA) the Stock That Will Go to the Moon According to Reddit?January 15, 2025 | insidermonkey.comModerna’s Financial Outlook: Hold Rating Amidst Competitive Challenges and Strategic AdjustmentsJanuary 15, 2025 | markets.businessinsider.comModerna price target lowered to $38 from $70 at Morgan StanleyJanuary 15, 2025 | markets.businessinsider.comModerna's Road To Stopping The RedJanuary 15, 2025 | seekingalpha.comMorgan Stanley Lowers Moderna (NASDAQ:MRNA) Price Target to $38.00Morgan Stanley dropped their price target on shares of Moderna from $70.00 to $38.00 and set an "equal weight" rating for the company in a research note on Wednesday.January 15, 2025 | marketbeat.comQ4 Earnings Estimate for Moderna Issued By Leerink PartnrsModerna, Inc. (NASDAQ:MRNA - Free Report) - Analysts at Leerink Partnrs issued their Q4 2025 EPS estimates for Moderna in a research report issued to clients and investors on Monday, January 13th. Leerink Partnrs analyst M. Foroohar anticipates that the company will post earnings of ($2.54) per sJanuary 15, 2025 | marketbeat.comModerna Faces Financial Uncertainty Amid Market Competition and Revenue ChallengesJanuary 15, 2025 | markets.businessinsider.comIs Moderna Stock a No-Brainer Buy on the Sell-Off?January 15, 2025 | fool.comModerna May Have The Best Shot At A Vaccine For Stomach FluJanuary 14, 2025 | forbes.comModerna’s Financial Outlook Dims Amid Vaccine Challenges and Revised Sales Forecasts, Warrants Sell RatingJanuary 14, 2025 | markets.businessinsider.comModerna stock drops on lower 2025 guidance, more cost cutsJanuary 14, 2025 | bizjournals.comModerna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?January 14, 2025 | msn.comHere’s Why Moderna, Inc. (MRNA) Is Among Monday’s Top LosersJanuary 14, 2025 | msn.comWatch These Moderna Price Levels as Stock Plummets After Slashing 2025 Revenue OutlookJanuary 13, 2025 | investopedia.comModerna Shares Plunge After Predicting Steep 2025 Sales DeclineJanuary 13, 2025 | msn.comS&P 500 Gains and Losses Today: Moderna Plunges After Big Cut to Sales ForecastJanuary 13, 2025 | investopedia.com Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼-0.040.44▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼6724▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News argenx News BioNTech News Teva Pharmaceutical Industries News BeiGene News Summit Therapeutics News Genmab A/S News Viatris News Intra-Cellular Therapies News Dr. Reddy's Laboratories News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRNA Stock Alerts